Definium Therapeutics Inc (DFTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,408 | -18,451 | -93,036 | -76,207 | -59,011 |
| Depreciation Amortization | 1,600 | 780 | 2,616 | 1,828 | 1,039 |
| Accounts payable and accrued liabilities | -3,429 | -843 | 1,282 | 634 | -51 |
| Other Working Capital | -2,247 | 1,013 | 1,880 | -1,985 | 2,496 |
| Other Operating Activity | 11,491 | 4,635 | 41,434 | 37,739 | 34,318 |
| Operating Cash Flow | $-27,993 | $-12,866 | $-45,824 | $-37,991 | $-21,209 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | N/A | N/A | -297 | -297 | -297 |
| Other Investing Activity | 0 | 0 | 0 | -113 | -86 |
| Investing Cash Flow | $N/A | $N/A | $-297 | $-410 | $-383 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 831 | 241 | 98,824 | 98,697 | 97,877 |
| Other Financing Activity | -407 | -407 | 0 | 0 | 0 |
| Financing Cash Flow | $424 | $-166 | $98,824 | $98,697 | $97,877 |
| Exchange Rate Effect | -229 | -35 | 742 | 5,529 | 719 |
| Beginning Cash Position | 133,539 | 133,539 | 80,094 | 80,094 | 80,094 |
| End Cash Position | 105,741 | 120,472 | 133,539 | 145,919 | 157,098 |
| Net Cash Flow | $-27,798 | $-13,067 | $53,445 | $65,825 | $77,004 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,993 | -12,866 | -45,824 | -37,991 | -21,209 |
| Free Cash Flow | -27,993 | -12,866 | -45,824 | -37,991 | -21,209 |